ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W206. A total of 66 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 1.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,941,971 | -19.8% | 1,341,549 | +0.5% | 0.00% | – |
| Q2 2023 | $9,900,372 | -18.4% | 1,334,282 | +3.9% | 0.00% | – |
| Q1 2023 | $12,132,855 | +2.0% | 1,283,900 | +14.9% | 0.00% | – |
| Q4 2022 | $11,896,593 | +50.8% | 1,117,051 | +4.5% | 0.00% | – |
| Q3 2022 | $7,889,000 | +53.4% | 1,068,947 | 0.0% | 0.00% | – |
| Q2 2022 | $5,142,000 | +17.2% | 1,068,947 | +24.5% | 0.00% | – |
| Q1 2022 | $4,388,000 | -15.6% | 858,837 | -0.8% | 0.00% | – |
| Q4 2021 | $5,202,000 | -32.3% | 865,589 | -0.1% | 0.00% | – |
| Q3 2021 | $7,679,000 | +18.4% | 866,731 | +5.7% | 0.00% | – |
| Q2 2021 | $6,483,000 | +48.6% | 819,642 | +43.2% | 0.00% | – |
| Q1 2021 | $4,363,000 | +0.1% | 572,520 | +2.5% | 0.00% | – |
| Q4 2020 | $4,358,000 | -10.9% | 558,780 | +10.8% | 0.00% | – |
| Q3 2020 | $4,889,000 | – | 504,495 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sentinus, LLC | 149,050 | $1,408,523 | 0.47% |
| Intrepid Financial Planning Group LLC | 19,000 | $179,550 | 0.09% |
| PERRITT CAPITAL MANAGEMENT INC | 12,000 | $113,400 | 0.06% |
| Interchange Capital Partners, LLC | 11,413 | $107,853 | 0.06% |
| Virtu Financial LLC | 21,650 | $205 | 0.02% |
| CREATIVE FINANCIAL DESIGNS INC /ADV | 15,000 | $141,750 | 0.02% |
| J. Goldman & Co LP | 42,228 | $399,055 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 63,966 | $604,479 | 0.02% |
| KENNEDY CAPITAL MANAGEMENT LLC | 46,311 | $437,639 | 0.01% |
| 683 Capital Management, LLC | 16,000 | $151,200 | 0.01% |